Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
Ampronix
Schiller

X-Rays, Gamma Rays Alter Specific Small Molecules in the Blood

By Medimaging International staff writers
Posted on 06 Mar 2013
Cancer researchers have identified molecules in the bloodstream that might effectively assess the probability of radiation illness after exposure to ionizing radiation.

The animal study, led by researchers from the Ohio State Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James; Columbus, USA), revealed that gamma rays or X-rays alter the levels of specific molecules called microRNA in the blood in a predictable way.

If confirmed in human subjects, the findings could lead to new technology for quickly detecting individuals at risk for acute radiation syndrome after occupational exposures or accidents such as the recent Fukushima Daiichi nuclear reactor incident. The microRNA markers might also help physicians strategize customized radiation therapy for individual patients by taking into account how different people respond to radiation treatment, the researchers reported.

The study’s findings were reported February 25, 2013, in the journal PLOS ONE. “Our paper reports the identification of a panel of microRNA markers in mice whose serum levels provide an estimate of radiation response and of the dose received after an exposure has occurred,” said senior author Dr. Arab Chakravarti, chair and professor of radiation oncology, and codirector of the Brain Tumor Program. “Accurate dose evaluation is critical for making medical decisions and for the timely administration of therapy to prevent or reduce acute and late effects.”

The findings might also one day allow clinicians to assess radiation toxicity during the course of therapy based on an individual’s biology. “This would particularly benefit leukemia and lymphoma patients who receive total body irradiation in preparation for stem-cell transplantation,” Dr. Chakravarti remarked.

First author Dr. Naduparambil Jacob, a research assistant professor in radiation oncology, noted that the study could be an important step in the development of biologic dosimetry, or biodosimetry, a technology for identifying people at risk for acute radiation illnesses that develop within weeks of radiation exposure, and cancers and degenerative diseases that can occur months or years later. “Biodosimetry is an emerging concept that could enable us to identify individuals who need immediate treatment after a radiation exposure and to better develop personalized radiation treatment plans for patients,” Dr. Jacob explained.

For this study, Drs. Chakravarti, Jacob and their colleagues evaluated dose-dependent changes in levels of 88 individual microRNAs in serum from mice after a single acute radiation exposure, and after fractionated doses of radiation that are typical of radiation treatment prior to stem-cell transplantation. Samples were collected from exposed and control animals 24 or 48 hours after exposure.

Significant findings of the study included: (1) After a one-time exposure, miRNA-150 showed a clear decrease over time with increasing radiation dose, with a drop of 30% after 24 hours and of 50% after 48 hours, even at the lowest exposure of one gray of radiation. (2) miRNA-200b and miRNA-762 showed increased levels after radiation exposure, with the changes more pronounced in animals receiving higher doses. (3) Lastly, animals receiving fractioned doses showed similar changes; e.g., miRNA-150 decreased about 50% after 24 hours in animals receiving 4 Gray.

Related Links:

Ohio State Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute



Channels

MRI

view channel
Image: The Micronor M303 Encoding Sensor with A/B Quadrature Pulse Train Background (Photo courtesy of Micronor).

World’s First MRI-Safe Linear Encoder for Medical Applications Announced

A company specialized in producing fiber optic kinetic sensors, has developed a first-of-a-kind passive, optical, non-electronic, high-precision encoder for use in medical Magnetic Resonance Imaging (MRI).... Read more

Ultrasound

view channel
Image: The Lumify, app-based ultrasound system (Photo courtesy of Philips).

Philips Debuts First App-Based Ultrasound

An app-based ultrasound solution aims extending the reach of ultrasound applications using mobile technology. The app was presented at the Social Media and Critical Care conference, June, 23–26, 2015... Read more

Nuclear medicine

view channel

Hybrid Scanner Using Five Molecular Imaging Techniques Under Development

Scientists are developing a new molecular, preclinical hybrid imaging system to help find new drugs and to advance imaging research. The scanner was presented at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI; Reston, Virginia, USA), and consists of a window for tissue observation,... Read more

General/Advanced Imaging

view channel

FDA Approves Trial for Intraoperative Image-Guided Cancer Surgery System

The US Food and Drug Administration (FDA) has provided Investigational Device Exemption (IDE) approval for company to trial a new image-guided cancer surgery system for intraoperative imaging of breast cancer. The surgical system consists of a cancer-specific molecular imaging agent, and a lightweight hand-held single-cell... Read more

Imaging IT

view channel
Image: Siemens radiation therapy Syngo.via image suite (Photo courtesy of Siemens Healthcare).

New Version of Syngo.via Supports Treatment Decision in Oncology

Siemens Healthcare has released a new version of oncology diagnostics software that helps physicians plan the best course of treatment for cancer patients. Cancer treatment requires comprehensive diagnostics,... Read more

Industry News

view channel
Image: The Westchester Medical Center in Valhalla, NY, USA (Photo courtesy of Business Wire).

Philips to Provide Multi-Year USD 500 Million in Healthcare Services in the USA

Royal Philips (Amsterdam, the Netherlands) and the Westchester Medical Center Health Network (WMCHealth; Valhalla, NY, USA) have announced USD 500 million multi-year partnership. Philips will provide... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.